Catherine Pollock brings extensive experience in business development, market education, and investor and advisor relations.
Colin Hurst brings an interest in science, innovation, and a lighter environmental footprint.
Damien Fischer begins his role on July 1, 2020
Stuart McKinnon has been acting in the role since mid-March.
Steve Sibulkin to drive photogenics firm’s continued product development efforts and global growth.
Rachael Everitt joins the team in a newly created role.
Scott O’Donnell has been appointed as acting CEO of the group.
Dr Helen Anderson will be in the role for the next 12 months.
Melanie Dyer will replace the recently retired Sara Lunam.
Dr Tanira Kingi will join the board from July 1, 2020.
